Effectiveness and Safety of Apixaban for Treatment of Venous Thromboembolism in Daily Practice

Introduction  Phase 3 trials have shown comparable efficacy of direct oral anticoagulants (DOACs) and vitamin K antagonists in patients with acute venous thromboembolism (VTE), with less major bleeding events in patients randomized to DOAC treatment. With DOACs being increasingly used in clinical pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:TH Open
Principais autores: Hendriks, Stephan V., Klok, Frederikus A., Stenger, Wilhelmina J.E., Mairuhu, Albert T.A., Eikenboom, Jeroen, Fogteloo, Jaap, Huisman, Menno V.
Formato: Artigo
Idioma:Inglês
Publicado em: Georg Thieme Verlag KG 2020
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7314657/
https://ncbi.nlm.nih.gov/pubmed/32607465
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0040-1713683
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados